Market Overview:
The global veterinary/animal vaccines market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for animal-derived food products, rising awareness about animal health and zoonotic diseases, and technological advancements in vaccine development. The live attenuated vaccines segment is projected to grow at the highest CAGR during the forecast period. This growth can be attributed to their ability to provide long-term immunity and better safety profile as compared with other vaccine types. The hospitals and clinics segment is estimated to account for the largest share of the global veterinary/animal vaccines market in 2018.
Product Definition:
Veterinary vaccines are used to prevent diseases in animals. They work by exposing the animal to a “dead” or “modified” form of the virus. This will help create immunity against that particular virus. There are many different types of veterinary vaccines, but some of the most common ones include rabies, distemper, and parvovirus. Vaccinating animals is important because it can help protect them from serious illnesses that can cause death or severe health problems.
Live Attenuated Vaccines:
Live attenuated vaccines are also known as attenuated or toxoid vaccines. They are prepared by the process of live virus cultivation and are used to stimulate immunity in animals and humans. The vaccine is usually given to people who can’t get vaccinated through other means, such as an immunization against smallpox.
Inactivated Vaccines:
Inactivated vaccines are those vaccines which have been rendered inactive or inoperative for the purpose of immunization by heat-treatment, chemical treatment, or micro-organisms. In some instances, live attenuated vaccine may also be considered as inactivated. The most commonly used method for producing inactivated vaccine is to expose the virus to high temperature (42 degrees C - 50 degrees C) for a period sufficient to kill all viruses but not affect the protein content of the final product.
Application Insights:
Based on the application, the market is segmented into hospitals and clinics, zoos and wildlife parks, others (farms/ranches). The hospitals and clinics segment dominated the overall industry in terms of revenue in 2017. This was due to factors such as increasing pet ownership coupled with a rise in demand for preventive healthcare. Moreover, governments are making efforts towards improving veterinary care by establishing veterinary colleges or expanding existing ones. For instance, according to an article published by The Economist in 2018 titled ¢â‚¬Å“The Veterinary College Boom In India¢â‚¬ stated that over 100 new veterinary schools have been established since 2010 across India which has resulted in increased production of animal vaccines at local levels resulting in higher consumption globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as high animal population, rising pet ownership, and increasing awareness about veterinary health. Moreover, the presence of major players in this region is expected to boost revenue growth over the forecast period. The U.S., which is one of the most lucrative markets for pharmaceutical companies due to its advanced healthcare infrastructure and high purchasing power of consumers also happens to be a major market for veterinary vaccines with around 80 million pets present in this country alone (estimates vary).
Asia Pacific is estimated to witness significant growth over the coming years owing to rapid economic development coupled with increasing per capita income among people; thereby leading them towards a better lifestyle including having more money for luxury goods including pets’ vaccination services.
Growth Factors:
- Increasing demand for animal-derived food products is expected to drive the growth of the veterinary vaccines market.
- Growing awareness about zoonotic diseases and their prevention is anticipated to boost the demand for veterinary vaccines over the forecast period.
- Rising number of pet ownership is projected to fuel the growth of this market in near future.
- Technological advancements in vaccine development are likely to create new opportunities for players operating in this market during forecast period. 5) Stringent regulations by governments regarding animal health and safety are expected to propel the growth of veterinary vaccines market during forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Veterinary/Animal Vaccines Market Research Report
By Type
Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines
By Application
Hospitals and Clinics, Others
By Companies
Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Virbac, Vetoquinol, Phibro Animal Health, Hester, Hipra, Idt Biologika, Biogenesis Bago, Tianjin Ringpu, China Animal Husbandry
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Veterinary/Animal Vaccines Market Report Segments:
The global Veterinary/Animal Vaccines market is segmented on the basis of:
Types
Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis
- Merck Animal Health
- Boehringer Ingelheim
- Elanco
- Virbac
- Vetoquinol
- Phibro Animal Health
- Hester
- Hipra
- Idt Biologika
- Biogenesis Bago
- Tianjin Ringpu
- China Animal Husbandry
Highlights of The Veterinary/Animal Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Other Vaccines
- By Application:
- Hospitals and Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Veterinary/Animal Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Veterinary/animal vaccines are a type of vaccine that is used to protect animals from diseases. Veterinary/animal vaccines can be used to protect animals from diseases that can be harmful, such as rabies, chickenpox, and parvovirus.
Some of the major companies in the veterinary/animal vaccines market are Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Virbac, Vetoquinol, Phibro Animal Health, Hester, Hipra, Idt Biologika, Biogenesis Bago, Tianjin Ringpu, China Animal Husbandry.
The veterinary/animal vaccines market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Veterinary/Animal Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Veterinary/Animal Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Veterinary/Animal Vaccines Market - Supply Chain
4.5. Global Veterinary/Animal Vaccines Market Forecast
4.5.1. Veterinary/Animal Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Veterinary/Animal Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Veterinary/Animal Vaccines Market Absolute $ Opportunity
5. Global Veterinary/Animal Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Veterinary/Animal Vaccines Market Size and Volume Forecast by Type
5.3.1. Live Attenuated Vaccines
5.3.2. Inactivated Vaccines
5.3.3. Toxoid Vaccines
5.3.4. Recombinant Vaccines
5.3.5. Other Vaccines
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Veterinary/Animal Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Veterinary/Animal Vaccines Market Size and Volume Forecast by Application
6.3.1. Hospitals and Clinics
6.3.2. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Veterinary/Animal Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Veterinary/Animal Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Veterinary/Animal Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Veterinary/Animal Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Veterinary/Animal Vaccines Demand Share Forecast, 2019-2026
9. North America Veterinary/Animal Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Veterinary/Animal Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Veterinary/Animal Vaccines Market Size and Volume Forecast by Application
9.4.1. Hospitals and Clinics
9.4.2. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Veterinary/Animal Vaccines Market Size and Volume Forecast by Type
9.7.1. Live Attenuated Vaccines
9.7.2. Inactivated Vaccines
9.7.3. Toxoid Vaccines
9.7.4. Recombinant Vaccines
9.7.5. Other Vaccines
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Veterinary/Animal Vaccines Demand Share Forecast, 2019-2026
10. Latin America Veterinary/Animal Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Veterinary/Animal Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Veterinary/Animal Vaccines Market Size and Volume Forecast by Application
10.4.1. Hospitals and Clinics
10.4.2. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Veterinary/Animal Vaccines Market Size and Volume Forecast by Type
10.7.1. Live Attenuated Vaccines
10.7.2. Inactivated Vaccines
10.7.3. Toxoid Vaccines
10.7.4. Recombinant Vaccines
10.7.5. Other Vaccines
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Veterinary/Animal Vaccines Demand Share Forecast, 2019-2026
11. Europe Veterinary/Animal Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Veterinary/Animal Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Veterinary/Animal Vaccines Market Size and Volume Forecast by Application
11.4.1. Hospitals and Clinics
11.4.2. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Veterinary/Animal Vaccines Market Size and Volume Forecast by Type
11.7.1. Live Attenuated Vaccines
11.7.2. Inactivated Vaccines
11.7.3. Toxoid Vaccines
11.7.4. Recombinant Vaccines
11.7.5. Other Vaccines
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Veterinary/Animal Vaccines Demand Share, 2019-2026
12. Asia Pacific Veterinary/Animal Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Veterinary/Animal Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Veterinary/Animal Vaccines Market Size and Volume Forecast by Application
12.4.1. Hospitals and Clinics
12.4.2. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Veterinary/Animal Vaccines Market Size and Volume Forecast by Type
12.7.1. Live Attenuated Vaccines
12.7.2. Inactivated Vaccines
12.7.3. Toxoid Vaccines
12.7.4. Recombinant Vaccines
12.7.5. Other Vaccines
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Veterinary/Animal Vaccines Demand Share, 2019-2026
13. Middle East & Africa Veterinary/Animal Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Veterinary/Animal Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Veterinary/Animal Vaccines Market Size and Volume Forecast by Application
13.4.1. Hospitals and Clinics
13.4.2. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Veterinary/Animal Vaccines Market Size and Volume Forecast by Type
13.7.1. Live Attenuated Vaccines
13.7.2. Inactivated Vaccines
13.7.3. Toxoid Vaccines
13.7.4. Recombinant Vaccines
13.7.5. Other Vaccines
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Veterinary/Animal Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Veterinary/Animal Vaccines Market: Market Share Analysis
14.2. Veterinary/Animal Vaccines Distributors and Customers
14.3. Veterinary/Animal Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Zoetis
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck Animal Health
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boehringer Ingelheim
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Elanco
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Virbac
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Vetoquinol
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Phibro Animal Health
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hester
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Hipra
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Idt Biologika
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Biogenesis Bago
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Tianjin Ringpu
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. China Animal Husbandry
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
